# Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity

> **NCT02486042** · PHASE2 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 48 (actual)

## Conditions studied

- Retinopathy of Prematurity

## Interventions

- **DRUG:** Omegaven
- **DIETARY_SUPPLEMENT:** Standard lipids (primarily omega-6 fatty acids)

## Key facts

- **NCT ID:** NCT02486042
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02486042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02486042, "Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02486042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*